Survival Comparison Amongst Commonly Used Frontline Regimens in Patients Age 70 Years and Older with Acute Myeloid Leukemia (AML): A Single-Institution Study of Over 600 Patients

Optimal frontline therapy for elderly patients with AML remains controversial. In this large, single-institution retrospective cohort study of AML patients over age 70, we present survival analysis and comparison amongst a variety of commonly used regimens.

Source: Clinical Lymphoma, Myeloma and Leukemia - August 26, 2016 Category: Hematology Authors: Varun Dhulipala, Martine Extermann, Najla Al Ali, Jongphil Kim, Marina Sehovic, Tea Reljic, Benjamin Djulbegovic, Jeffrey Lancet Source Type: research